David R. Corey

David R. Corey is a Professor in the Department of Pharmacology at the University of Texas Southwestern Medical Center's School of Medicine, holding a secondary appointment in the Department of Biochemistry. He has been a faculty member since 1992, progressing from Assistant Professor to Associate Professor in 1998 and Full Professor in 2003.

His educational background includes:

• BA in Chemistry from Harvard University (1985)
• PhD in Chemistry from University of California at Berkeley (1990)
• Postdoctoral training with Dr. Charles Craik at University of California at San Francisco (1990-1992)

Dr. Corey's research focuses on nucleic acid therapeutics, particularly antisense oligonucleotides and RNA interference technologies. His laboratory investigates how synthetic nucleic acids can target disease-causing RNA molecules, with significant work on trinucleotide repeat disorders including spinal muscular atrophy, Duchenne muscular dystrophy, and Fuchs' endothelial corneal dystrophy. His research bridges fundamental molecular mechanisms with therapeutic applications, exploring nuclear RNA interference pathways and novel delivery strategies.

Analysis of his publication trends shows consistent innovation in RNA-targeting therapeutics, with recent work emphasizing nuclear aspects of gene regulation and overcoming challenges in allele-selective inhibition. His contributions have directly informed multiple FDA-approved oligonucleotide therapies.

Dr. Corey has established himself as a leader in translating basic RNA research into clinical applications, with his work appearing in top journals including Nature, Cell, and Nucleic Acids Research. His research program continues to advance the frontier of nucleic acid-based treatments for genetic disorders.